The guideline recommendations advise universal use of hydroxychloroquine, minimizing steroids, and earlier introduction of ...

The stock's fall snapped a three-day winning streak.

Biogen Canada Inc. is disappointed by INESSS's recommendation against listing SKYCLARYS™ (omaveloxolone), despite its therapeutic potential for individuals living with Friedreich ataxia (FA) — a ...

DelveInsight's Friedreich's Ataxia Market Insights report includes a comprehensive understanding of current treatment ...

Krystal Biotech (KRYS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The global Oligonucleotide Synthesis Market, valued at US$8.9 billion in 2024 stood at US$10.5 billion in 2025 and is projected to advance at ...

BOSTON and SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., a clinical-stage biopharmaceutical ...

Going forward, Celltrion is expected to continue its current strategy, aiming to have a total of 23 biosimilar products by 2030, covering therapeutic areas such as immunology and oncology. Leveraging ...

US stocks finished in the red on Thursday as investors turned cautious ahead of the non-farm payrolls report, while shares in ...